Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non-small-cell lung cancer: a propensity-matched retrospective study

Wang, X; Zeng, ZM; Cai, J; Xu, P; Liang, PA; Luo, YX; Liu, AW

Liu, AW (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Oncol, 1 Minde St, Nanchang 330000, Jiangxi, Peoples R China.

BMC CANCER, 2021; 21 (1):

Abstract

Background This retrospective study aimed to evaluate the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with s......

Full Text Link